Armstrong Shaw Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $221K | Hold |
2,950
| – | – | 0.23% | 41 |
|
|
2023
Q2 | $227K | Hold |
2,950
| – | – | 0.23% | 44 |
|
|
2023
Q1 | $245K | Hold |
2,950
| – | – | 0.24% | 44 |
|
|
2022
Q4 | $253K | Buy |
+2,950
| New | +$253K | 0.25% | 37 |
|
|
2022
Q1 | – | Sell |
-2,950
| Closed | -$214K | – | 44 |
|
|
2021
Q4 | $214K | Hold |
2,950
| – | – | 0.17% | 43 |
|
|
2021
Q3 | $206K | Hold |
2,950
| – | – | 0.18% | 42 |
|
|
2021
Q2 | $203K | Buy |
+2,950
| New | +$203K | 0.18% | 43 |
|
|
2020
Q3 | – | Sell |
-2,950
| Closed | -$227K | – | 41 |
|
|
2020
Q2 | $227K | Hold |
2,950
| – | – | 0.28% | 41 |
|
|
2020
Q1 | $221K | Buy |
+2,950
| New | +$221K | 0.28% | 41 |
|
|
2018
Q4 | – | Sell |
-2,950
| Closed | -$228K | – | 40 |
|
|
2018
Q3 | $228K | Hold |
2,950
| – | – | 0.2% | 41 |
|
|
2018
Q2 | $209K | Hold |
2,950
| – | – | 0.19% | 43 |
|
|
2018
Q1 | $222K | Hold |
2,950
| – | – | 0.2% | 40 |
|
|
2017
Q4 | $211K | Hold |
2,950
| – | – | 0.18% | 41 |
|
|
2017
Q3 | $239K | Hold |
2,950
| – | – | 0.22% | 39 |
|
|
2017
Q2 | $209K | Hold |
2,950
| – | – | 0.08% | 41 |
|
|
2017
Q1 | $200K | Hold |
2,950
| – | – | 0.05% | 42 |
|
|
2016
Q4 | $211K | Hold |
2,950
| – | – | 0.05% | 44 |
|
|
2016
Q3 | $233K | Buy |
+2,950
| New | +$233K | 0.06% | 47 |
|